Jennifer Ciresi
@Redmile Group, Llc
Latest period2024 - Q3ReportedManaged Assets$1.697BTotal holdings63
Assets growth rate2.63%Assets growth rate (2-Q avg)-18.33%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Redmile Group, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Redmile Group, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.697B in assets, with a quarterly growth rate of 2.63% and a 2-quarter average growth rate of -18.33%. The portfolio is managed by Jennifer Ciresi, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ANNXAnnexon Inc
| 2.25% | $38.051M 6.427M shares@ $5.92 avg price | |
CTLTCatalent Inc
| 2.13% | $36.074M 595,570 shares@ $60.58 avg price | |
PLRXPliant Therapeutics Inc
| 2.12% | $35.844M 3.197M shares@ $11.21 avg price | Decreased -0.37% |
SLNSilence Therapeutics Plc
| 2.04% | $34.53M 1.899M shares@ $18.18 avg price | Decreased -5.7% |
KROSKeros Therapeutics Inc
| 1.9% | $32.084M 552,506 shares@ $58.07 avg price | |
ABSIAbsci Corporation
| 1.86% | $31.528M 8.253M shares@ $3.82 avg price | |
BSXBoston Scientific Corp
| 1.64% | $27.727M 330,873 shares@ $83.8 avg price | Decreased -15.21% |
CLDXCelldex Therapeutics Inc New
| 1.32% | $22.337M 657,175 shares@ $33.99 avg price | Decreased -8.56% |
IDYAIdeaya Biosciences Inc
| 1.28% | $21.579M 681,150 shares@ $31.68 avg price | Decreased -10.31% |
STTKShattuck Labs Inc
| 1.16% | $19.598M 5.615M shares@ $3.5 avg price |